Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Visudyne verteporfin: Began Phase IIIb trial enrollment

QLT PhotoTherapeutics Inc. (TSE:QLT; QLTI), Vancouver, B.C.
Product: Visudyne

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE